More and more, artificial intelligence (AI) influences what most of us do every day.
AI is increasingly behind the songs proposed to us through our music subscriptions and the shows selected for us personally on streaming platforms. AI suggests changes to our writing; prompts traffic signals to alter their pattern; and, interestingly, serves as a launching pad for new ideas, new designs, and new developments in healthcare. Across the spectrum of human activity, AI affects how people live their daily lives.
We here at JB Ashtin are using AI; it’s an exciting new tool, and we are committed to staying at the forefront. To ensure that we use AI carefully, selectively, and responsibly, we’ve crafted this perspective to serve as our policy:
At JB Ashtin, we integrate artificial intelligence (AI) selectively to ignite creative solutions, refine our research, and shape initial drafts for a variety of projects. We use AI to complement our creativity, critical thinking, and deep expertise in medical communications, while ensuring that we do not compromise client confidentiality or data integrity. Our ongoing monitoring of AI’s evolving role in the pharma and biotechnology industries shapes our responsible approach. We stand for stringent governance in the use of AI, ensuring it aligns with the highest ethical and operational standards in pharma/biotech and medical communications.
Used in this way, AI is like a partner in a brainstorming session, serving as an add-on to our creativity and a riposte to our own thinking. Although we’re experts in medical communications, it’s fruitful to be challenged by this neutral third party that helps us consider alternative perspectives, and to connect ideas in unexpected ways.
Throughout history, policies, practices, and even the laws that govern us fall into place only after technological developments. (Case in point: the creation of social media platforms and smartphones has led to increasing international privacy standards and laws.) However, we’re unable to wait for government or external guidance to shape our approach to AI — it’s already part of our reality. Therefore, we want to assure you that we’re committed to stringent governance in the use of AI. We continually monitor advancements in AI within the field of pharma/biotech and medical communications and are keeping a close eye on evolving legislation.
While we use AI to spur our creativity, we continue to place the responsible healthcare of humans at the center of what’s most important.